(Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's ...

President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.

Pfizer (PFE) shares slipped on Wednesday after The Wall Street Journal reported that U.S. authorities are investigating ...

Inquiry looks into a politically explosive suggestion that Pfizer in 2020 delayed announcing a successful vaccine against ...

The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...

Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...

With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

How to get a test President Donald Trump has claimed in the past that Pfizer sat on positive data from the vaccine's clinical trials, but there has never been evidence to support the accusation.

U.S. prosecutors are looking into a claim that GSK (GSK) scientist, who formerly worked at Pfizer (PFE), told colleagues that Pfizer delayed ...

Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot’s success in 2020 until after that year’s election, the Wall Street Journal reported ...

President Donald Trump has claimed in the past that Pfizer sat on positive data from the vaccine's clinical trials, but there has never been evidence to support the accusation. The U.S. attorney's ...